Abstract
BackgroundChronic kidney disease is an increasingly common health problem for Aboriginal and Torres Strait Islander people. It is associated with multiple concurrent psychosocial stressors frequently resulting in negative impacts on emotional and social wellbeing. There is need for well-designed intervention studies to provide evidence of effective treatment for comorbid depression or other mental illness in this setting. Attention to early phase piloting and development work is recommended when testing complex interventions. This paper documents feasibility testing and adaptation of an existing culturally responsive brief wellbeing intervention, the Stay Strong App, and three commonly used wellbeing outcome measures, in preparation for a clinical trial testing effectiveness of the intervention.MethodsThe Stay Strong App, which has not been used in the setting of Chronic Kidney Disease before, is reviewed and adapted for people with comorbid wellbeing concerns through expert consensus between research team and an Expert Panel. The outcome measures (Kessler 10, Patient Health Questionnaire 9, and EuroQoL) are valid, reliable, and commonly used tools to assess various aspects of wellbeing, which have also not been used in this context before. Feasibility and acceptability are examined and developed through 3 stages: Pilot testing in a purposive sample of five haemodialysis patients and carers; translation of outcome measures through collaboration between the Aboriginal Interpreter Service, Aboriginal and Torres Strait Islander research officers and the research team; and conversion of translated outcome measures to electronic format.ResultsResearch team and expert panel consensus led to adaptation of the Stay Strong App for renal patients through selective revision of words and images. Pilot testing identified challenges in delivery of the wellbeing measures leading to word changes and additional prompts, integration of audio translations in 11 local Indigenous languages within an interactive Outcome Measures App, and related research protocol changes.ConclusionModelling the complex intervention prior to full-scale testing provided important information about the design of both the outcome measures and the intervention. These changes are likely to better support success in conduct of the clinical trial and future implementation of the intervention in clinical settings.
Highlights
Chronic kidney disease is an increasingly common health problem for Aboriginal and Torres Strait Islander people
Stage 1: Pilot testing of outcome measures Three haemodialysis patients and two carers who spoke English as a second or third language participated in the pilot testing process through two individual and one group interviews
Aboriginal and Torres Strait Islander people with Chronic Kidney Disease Stage 5 (CKD-5) face many wellbeing challenges. Their unique experiences require the development of targeted interventions supported by evidence of effectiveness obtained through robust research design
Summary
Chronic kidney disease is an increasingly common health problem for Aboriginal and Torres Strait Islander people. It is associated with multiple concurrent psychosocial stressors frequently resulting in negative impacts on emotional and social wellbeing. There is need for well-designed intervention studies to provide evidence of effective treatment for comorbid depression or other mental illness in this setting. Chronic kidney disease (CKD) is a serious and increasingly common health problem for Aboriginal and Torres Strait Islander people, especially those who live in remote communities. The most recent National Biomedical Risk Factor Survey (2012–13), estimated that while 10% of Australians have biomedical signs of CKD, a higher proportion (23%) of Aboriginal and Torres Strait Islander adults were estimated to have CKD, with a heavier burden of 39% of adults affected in remote areas [2]. In 2012–13 the incidence rate of CKD-5 among Aboriginal and Torres Strait Islander Australians was 6.6 times that for nonAboriginal and Torres Strait Islander Australians, and Aboriginal and Torres Strait Islander Australians were 10 times as likely as non-Aboriginal and Torres Strait Islander Australians to be hospitalised for this disease [4]
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have